SPH(SPH)
SPH
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $1.39B | $1.45B | $1.47B | $1.48B |
| Low | $1.39B | $1.45B | $1.47B | $1.48B |
| High | $1.39B | $1.45B | $1.47B | $1.48B |
| EBITDA Avg | $258M | $269M | $272M | $274M |
| Low | $258M | $269M | $272M | $274M |
| High | $258M | $269M | $272M | $274M |
| EBIT Avg | $184M | $192M | $194M | $196M |
| Low | $184M | $192M | $194M | $196M |
| High | $184M | $192M | $194M | $196M |
| Net Income Avg | $134M | $129M | $132M | $132M |
| Low | $134M | $129M | $132M | $132M |
| High | $134M | $129M | $132M | $132M |
| EPS Avg | $2.04 | $1.97 | $2.01 | $2.02 |
| Low | $2.04 | $1.97 | $2.01 | $2.02 |
| High | $2.04 | $1.97 | $2.01 | $2.02 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 |
|---|---|
| Revenue Avg | $212M |
| Low | $212M |
| High | $212M |
| EBITDA Avg | $39M |
| Low | $39M |
| High | $39M |
| EBIT Avg | $28M |
| Low | $28M |
| High | $28M |
| Net Income Avg | $-39M |
| Low | $-39M |
| High | $-39M |
| EPS Avg | $-0.59 |
| Low | $-0.59 |
| High | $-0.59 |
| Analysts (Rev / EPS) | 1 / 1 |